Pharmaceutical and Medical Law: Legal Analytics and Insights

 

BRACE attorneys continuously monitor regulatory changes in the pharmaceutical and healthcare sectors. This section provides current legal analytics on the circulation of medicinal products, Dietary Supplements, and medical devices, alongside analyses of key court cases and regulatory trends in the life sciences industry.

 

The provided analytical framework illustrates the intersection of pharmaceutical marketing strategies and the restrictive regulatory requirements enforced by the Federal Antimonopoly Service (FAS).

False Advertising of Medicinal Products

Strategic map of the legal mechanisms and liability thresholds governing consumer rights within the Russian pharmaceutical supply chain.

Protection of Consumer Rights for Medicinal Products

Strategic categorization of medical devices by risk class (1, 2a, 2b, and 3) according to Russian regulatory standards, a critical prerequisite for successful Roszdravnadzor registration and market access.

Medical Device Classification in Russia: Risk Classes & Nomenclature

Analytical breakdown of the regulatory framework governing the expiration and quality maintenance of pharmaceuticals within the Russian Federation and EAEU.

Shelf Life of Medicinal Products: Russian Legal Regulation

Strategic map of the Russian regulatory environment governing the lifecycle and distribution of prescription-only medicines (POM), highlighting key compliance touchpoints for international manufacturers.

Prescription Medicinal Products in Russia: Legal Regulation

Regulatory criteria and legal benchmarks for determining the equivalence of medical devices within the Russian Federation's procurement and registration systems.

Interchangeability of Medical Devices

Strategic regulatory map illustrating the intersection of Russian advertising law, data protection, and pharmaceutical industry-specific transparency requirements for digital platforms.

Content Requirements for Pharmaceutical Company Websites

Strategic map of the regulatory requirements and licensing protocols governing the remote distribution of pharmaceutical products within the Russian Federation.

Remote Sale of Medicinal Products

Strategic map of the regulatory landscape governing pharmaceutical marketing communications, highlighting the intersection of the Law on Advertising and industry-specific healthcare legislation.

Promotion and Advertising of Medicinal Products in Russia: Legal Regulation

Comparative overview of prohibited and permitted collaborative activities between pharmaceutical manufacturers and medical practitioners under current Russian federal legislation.

Restrictions on Interactions Between Pharmaceutical Companies and Physicians

E-mail
info@brace-lf.com

Send us a request with a detailed description of the issue.

Our phone
+7 (495) 147-11-03

Contact us by phone.

Clients & Partners

65.png
68.png
69.png
73.png
75.png
fitera.jpg
imko.png
logo.png
Logo_RED_RGB_Rus.png
logo_SK_2.png